ENDOCRINE METABOLIC SYNDROME 2021
- About the Conference
- Who Should Attend?
- Abstract Eligibility Criteria
- Major Sessions
- Market Analysis
- Past Conference Report
Conference series is hosting the World congress on Endocrinology and Metabolic syndrome (ENDOCRINE METABOLIC SYNDROME 2021) during April 13-14, 2021 Webinar.
ENDOCRINE METABOLIC SYNDROME 2021 Conference is based on the theme of To "New guidance and experimental approaches in the treatment of endocrinal disorders and In Metabolic syndrome."
ENDOCRINE METABOLIC SYNDROME 2021 welcomes all the Endocrinologists and other medical & clinical experts working the arena of Endocrinology, Metabolic Syndrome and related field to this upcoming World congress on Endocrinology and Metabolic syndrome.
Endocrinology and Metabolic syndrome Congress composed of well-organized scientific sessions, plenary sessions, Oral presentations, Poster presentations, one to one meetings, networking sessions, e-poster presentation, Young Researcher Forums (YRFs), B2B meetings, International workshops, Symposiums, Industrial sessions, Exhibitor presentations etc.
ENDOCRINE METABOLIC SYNDROME 2021 welcome the Scientists, Doctors, Academician, Researchers, Students, Business Entrepreneurs, etc. related to the broad areas of Metabolic syndrome, Endocrinology, Medical and Health care, Diabetes and Endocrinology organizations are most likely to attend ENDOCRINE METABOLIC SYNDROME 2021 and utilize the scope of extending their skills, and their work on basic and significant applications. ENDOCRINE METABOLIC SYNDROME 2021 conference will be useful to participants from both the Industry and Academia working in all the domains of Health care sectors, all other target audience includes:
- Health care experts
- Diabetes Health Professionals
- Nurse practitioners
- Health care analysts
- Academic researchers
- Research Institutes
- Business delegates
- Young Researchers
- Advertising and Promotion Agency Executives
- Professionals in media sector
- Medical colleges
- Metabolic syndrome Societies & Associations
- Obesity Societies & Associations
- Heart Societies & Associations
- Medical & Pharmaceutical Companies
- Medical devices & companies
Individuals may submit an unlimited number of Trials in Progress abstracts
Individuals may serve as a co-author on an unlimited number of abstracts
All types of metabolic syndrome, Endocrinology, Medicinal, Health research are eligible for submission.
Abstracts should address scientific questions, detail clinical observations, or contain primary scientific data.
Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown.
Interim analysis of a prospective randomized clinical trial will be considered if it is performed as planned in the original protocol and is statistically valid.
Note: Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts
Provide your full name, academic degree(s), institution, address, and email address and recent photograph. You will receive all future correspondence from us regarding the status of your abstract.
The selected abstracts will be published in Conference Proceedings.
Early Bird Discount Registration Offer: On/Before April 10, 2021
Early Bird Abstract Submission Date: April 11, 2021
Abstract Submission Deadline: April 12, 2021
Speaker Presentations Sessions and Time limits:
Keynote Speech 40-45 Minutes,
Workshop/Symposium 60 Minutes
Plenary Speech 20-25 Minutes,
Poster Presentation 10-15 Minutes
Endocrinology is a branch medicine that deals with the endocrine system, its diseases, and its specific secretions such as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or Behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. The endocrine system consists of several glands, all in different parts of the body, that secrete hormones directly into the blood rather than into a duct system. Therefore, endocrine glands are regarded as ductless glands.
The “metabolic syndrome” (MetS) is a clustering of components that reflect over nutrition, sedentary lifestyles, and resultant excess adiposity. The MetS includes the clustering of abdominal obesity, insulin resistance, dyslipidemia, and elevated blood pressure and is associated with other comorbidities including the prothrombotic state, proinflammatory state, nonalcoholic fatty liver disease, and reproductive disorders. Because the MetS is a cluster of different conditions, and not a single disease, the development of multiple concurrent definitions has resulted. The prevalence of the MetS is increasing to epidemic proportions not only in the United States and the remainder of the urbanized world but also in developing nations. Most studies show that the Met’s is associated with an approximate doubling of cardiovascular disease risk and a 5-fold increased risk for incident type 2 diabetes mellitus. Although it is unclear whether there is a unifying pathophysiological mechanism resulting in the MetS, abdominal adiposity and insulin resistance appear to be central to the MetS and its individual components. Lifestyle modification and weight loss should, therefore, be at the core of treating or preventing the MetS and its components.
Metabolic syndrome is a cluster of conditions that occur together, increasing your risk of heart disease, stroke and type 2 diabetes. These conditions include increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels.Having just one of these conditions doesn't mean you have metabolic syndrome. But it does mean you have a greater risk of serious disease. And if you develop more of these conditions, your risk of complications, such as type 2 diabetes and heart disease, rises even higher.Metabolic syndrome is increasingly common, and up to one-third of U.S. adults have it. If you have metabolic syndrome or any of its components, aggressive lifestyle changes can delay or even prevent the development of serious health problems.
Endocrine disruptors are chemicals that can interfere with endocrine systems at certain doses. These disruptions can cause cancerous tumours, birth defects, and other developmental disorders. Any system in the body controlled by hormones can be derailed by hormone disruptors. Specifically, endocrine disruptors may be associated with the development of learning disabilities, severe attention deficit disorder, cognitive and brain development problems deformations of the body that includes breast cancer, prostate cancer, thyroid and other cancers; sexual development problems such as feminizing of males or masculinizing effects on females, etc.
Pediatric endocrinology is a medical subspecialty dealing with disorders of the endocrine glands, such as variations of physical growth and sexual development in childhood, diabetes and many more. By age, pediatric endocrinologists, depending upon the age range of the patients they treat, care for patients from infancy to late adolescence and young adulthood. The most common disease of the specialty is type 1 diabetes, which usually accounts for at least 50% of a typical clinical practice. The next most common problem is growth disorders, especially those amenable to growth hormone treatment. Pediatric endocrinologists are usually the primary physicians involved in the medical care of infants and children with intersex disorders.
The specialty also deals with hypoglycemia and other forms of hyperglycemia in childhood, variations of puberty, as well other adrenal, thyroid, and pituitary problems. Many pediatric endocrinologists have interests and expertise in bone metabolism, lipid metabolism, adolescent gynaecology, or inborn errors of metabolism. Training for pediatric endocrinology consists of a 3 year fellowship following completion of a 3 year paediatrics residency. The fellowship, and the specialty, are heavily research-oriented and academically based, although less exclusively now than in past decades.
Bone is living, growing tissue. It is made mostly of collagen, a protein that provides a soft framework, and calcium phosphate, a mineral that adds strength and hardens the framework. Vitamin D helps the body absorb and process calcium. Together, these two nutrients are the cornerstone of healthy bones.
Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased risk of fractures of the hip, spine, and wrist. There are many causes of osteoporosis. Not only do bones lose density with age, medications used to treat breast cancer, arthritis, asthma, Crohn's disease and Addison's disease can also lower bone density. Some illnesses such as hyperthyroidism, hypopituaritism and eating disorders also cause bones to lose strength.
Nutrition: Nutrition, especially calcium, plays an important role in preventing osteoporosis. In people who have healthy bones, adequate calcium intake on a daily basis is necessary to maintain bone health.
Living with the Disease: It is common to feel anxious about health or lifestyle when diagnosed with osteoporosis feelings of loneliness; depression and helplessness are all very common.
Exercises for Healthy Bones: Exercise is recommended for all people with osteoporosis, even people who have had a spine or hip fracture. Exercise is an important step towards protecting the bones, as it helps protect the spine, slows the rate of bone loss, and builds muscle strength, which can prevent falls
Calcium and Vitamin D: Calcium and Vitamin D are essential nutrients for proper bone health. Vitamin D helps to increase the absorption of calcium, ultimately building stronger bones. It also improves the function of muscles, improving your balance and decreasing the likelihood of falls, which can lead to fractures.
Multiple endocrine neoplasia is a group of disorders that affect the body's network of hormone-producing glands called the endocrine system. Hormones are chemical messengers that travel through the bloodstream and regulate the function of cells and tissues throughout the body. Multiple endocrine neoplasia typically involves tumours in at least two endocrine glands; tumors can also develop in other organs and tissues. These growths can be noncancerous or cancerous. If the tumours become cancerous, the condition can be life-threatening.
The major forms of multiple endocrine neoplasia are called type 1, type 2, and type 4. These types are distinguished by the genes involved, the types of hormones made, and the characteristic signs and symptoms. Many different types of tumours are associated with multiple endocrine neoplasia. Type 1 frequently involves tumours of the parathyroid glands, the pituitary gland, and the pancreas. Tumours in these glands can lead to the overproduction of hormones. The most common sign of multiple endocrine neoplasia type 1 is overactivity of the parathyroid glands.
The hypothalamus produces gonadotropin-releasing hormone which is released in a pulsatile fashion every 60 to 120 minutes. Its target organ, the anterior pituitary gland, responds to each pulse of gonadotropin-releasing hormone by producing a corresponding pulse of luteinizing hormone (LH) and, to a lesser degree, follicle-stimulating hormone (FSH). If the gonadotropin-releasing hormone pulses do not occur with the proper amplitude, frequency, and diurnal variation, may result of idiopathic hypogonadotropic hypogonadism. Continuous stimulation by gonadotropin-releasing hormone agonists actually suppresses pituitary release of LH and FSH and thus testosterone production
Testosterone is synthesized from cholesterol through several intermediate compounds, including dehydro epiandrosterone (DHEA) and dehydro epiandrosterone. Circulating testosterone is mostly protein bound, about 40% avidly bound to sex hormone binding globulin and 58% loosely bound to albumin Thus, only about 2% of circulating testosterone is bioavailable as free testosterone. This bioactive component of total testosterone is responsible for male characteristics, libido, bone and muscle mass.
Testosterone, DHT, and estradiol provide negative feedback on the hypothalamic-pituitary axis. In males, estradiol is the main inhibitor of LH production, whereas both estradiol and inhibin B, a peptide produced by Sertoli cells of the testes, inhibit production of FSH. In the presence of testosterone, FSH stimulates the Sertoli cells and induces spermatogenesis. In spermatogenesis, each germinal cell located adjacent to the Sertoli cells, undergoes differentiation into 16 primary spermatocytes, each of which generates 4 spermatids. Each spermatid matures into a spermatozoon. Spermatogenesis takes 72 to 74 days and yields about 100 million new spermatozoa each day. Upon maturation, spermatozoa are released into the rete testis, where they migrate to the epididymis and eventually to the vas deferens. Migration requires an additional 14 days. During ejaculation, spermatozoa are mixed with secretions from the seminal vesicles, prostate, and bulbourethral glands.
Hormonal interaction between the hypothalamus, anterior pituitary gland, and ovaries regulates the female reproductive system. The hypothalamus secretes a small peptide, gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone releasing hormone. GnRH regulates release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from specialized cells (gonadotropes) in the anterior pituitary gland. These hormones are released in short bursts every 1 to 4 hours. LH and FSH promote ovulation and stimulate secretion of the sex hormones estradiol and progesterone from the ovaries.
Oestrogen and progesterone circulate in the bloodstream almost entirely bound to plasma proteins. Only unbound estrogenic and progesterone appear to be biologically active. They stimulate the target organs of the reproductive system. They usually inhibit but, in certain situations may stimulate gonadotropin secretion. Central influences that regulate release of Gnarl include neurotransmitters and peptide. Such factors may inhibit release of Gnarl during childhood, and then initiate its release to induce puberty in early adolescence. Early in puberty, hypothalamic GnRH release becomes less sensitive to inhibition by estrogen and progesterone. The resulting increased release of Gnarl promotes LH and FSH secretion, which stimulates production of sex hormones, primarily estrogenic. Estrogen stimulates development of secondary sexual characteristics.
- Endocrinology and metabolic syndrome
- Complications of metabolic syndrome
- EDCs (Endocrine Disrupting Chemicals)
- Paediatric endocrinology
- Endocrine Glands and Hormones
- Bone Health and Osteoporosis
- Multiple endocrine Neoplasia
- Male Reproductive Endocrinology
- Female Reproductive Endocrinology
- Type 2 diabetes. If you don't make lifestyle changes to control your excess weight, you may develop insulin resistance, which can cause your blood sugar levels to rise. Eventually, insulin resistance can lead to type 2 diabetes.
- Heart and blood vessel disease. High cholesterol and high blood pressure can contribute to the build-up of plaques in your arteries. These plaques can narrow and harden your arteries, which can lead to a heart attack or stroke.
- Bisphenol A (BPA)
- Bisphenol S (BPS)
- Polychlorinated biphenyls
- Polybrominated diphenyl ethers
- Perfluorooctanoic acid
- Other suspected endocrine disruptors
- What is a Pediatric Endocrinologist?
- What Kind of Training Do Pediatric Endocrinologists Have?
- What Types of Treatment Do Pediatric Endocrinologists Provide?
- Pediatric Endocrinologists — the Best Care For Children
- Hypothalamus: The hypothalamus is located in the lower central part of the brain. This part of the brain is important in regulation of satiety, metabolism, and body temperature. In addition, it secretes hormones that stimulate or suppress the release of hormones in the pituitary gland.
- Pituitary gland: The pituitary gland is located at the base of the brain beneath the hypothalamus and is no larger than a pea. It is often considered the most important part of the endocrine system because it produces hormones that control many functions of other endocrine glands
- Pineal gland: The pineal body, or pineal gland, is located in the middle of the brain. It secretes a hormone called melatonin, which may help regulate the wake-sleep cycle of the body
- Thyroid gland: The thyroid gland is located in the lower front part of the neck. It produces thyroid hormones that regulate the body's metabolism. It also plays a role in bone growth and development of the brain and nervous system in children. The pituitary gland controls the release of thyroid hormones. Thyroid hormones also help maintain normal blood pressure, heart rate, digestion, muscle tone, and reproductive function
- Parathyroid: The parathyroid glands are two pairs of small glands embedded in the surface of the thyroid gland, one pair on each side. They release parathyroid hormone, which plays a role in regulating calcium levels in the blood and bone metabolism.
- Thymus: Thymus gland makes white blood cells called T-lymphocytes that fight infection and are crucial as a child's immune system develops. The thymus starts to shrink after puberty.
- Adrenal Glands: The two adrenal glands are triangular-shaped glands located on top of each kidney. The adrenal glands are made up of two parts. The outer part is called the adrenal cortex, and the inner part is called the adrenal medulla. The outer part produces hormones called corticosteroids, which regulate the body's metabolism, the balance of salt and water in the body, the immune system, and sexual function. The inner part, or adrenal medulla, produces hormones called catecholamines.
- Pancreas: The pancreas is an elongated organ located toward the back of the abdomen behind the stomach. The pancreas has digestive and hormonal functions. One part of the pancreas, the exocrine pancreas, secretes digestive enzymes. The other part of the pancreas, the endocrine pancreas, secretes hormones called insulin and glucagon. These hormones regulate the level of glucose in the blood.
- The reproductive glands: These glands are the main source of sex hormones. In males, the testes, located in the scrotum, secrete hormones called androgens; the most important of which is testosterone. These hormones affect many male characteristics like sexual development, growth of facial hair and pubic hair as well as sperm production. In females, the ovaries, located on both sides of the uterus, produce estrogen and progesterone as well as eggs. These hormones control the development of female characteristics such as breast growth, and they are also involved in reproductive function like menstruation, pregnancy
- Types of multiple endocrine neoplasia
- What are multiple endocrine neoplasia?
- How is multiple endocrine neoplasia?
- What are the treatment options for multiple endocrine neoplasia?
- The hypothalamic-pituitary-testicular (HPT) axis
- The GH, insulin-like growth factor (IGF)-1, and PRL effects
- The inhibin/activin-follistatin system
- Estrogen and testicular function
- Paracrine/autocrine regulation of testicular function
- Testicular apoptosis
- Aging and male endocrine function
- Ovarian Follicular Development
- Menstrual Cycle
- Cyclic Changes in Other Reproductive Organs
Global endocrinology drugs market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of endocrine diseases. These diseases include endocrine gland associated disorders such as Addison’s disease, gigantism, goiter, Cushing’s syndrome, polycystic ovary syndrome (PCOS), diabetes, hypertension, hyperlipidaemia, acromegaly, thyroiditis, and osteomalacia. Rising adolescent population base which is more prone to such diseases due to hormonal imbalances also tends to drive the growth of endocrinology drugs market. Unhealthy lifestyle characteristics such as high intake of cholesterol, work stress and weight gain which ultimately leading to malfunctioning of the endocrine system, inception of new drug delivery systems, extensive research and development, and the rise in disposable income propels the growth of endocrinology drugs market. Rapid uptake of novel dosage forms and formulations of existing drugs is expected to increase number of patients for treatment of endocrine disorders thus leading to market growth.
Regional analysis of Endocrinology
Major Associations of Endocrinology around the Global
- Endocrine Society
- American Association of Clinical Endocrinologists
- The American Association of Endocrine Surgeons
- Association of Program Directors in Endocrinology, Diabetes and Metabolism
- Society for Endocrinology
- Brazilian Society of Surgical Endocrinology
- British Society for Paediatric Endocrinology and Diabetes
- European Society of Endocrinology
- International Society of Endocrinology
- Paediatric Endocrine Society
Key players in Endocrinology
- Associations of Endocrinology in USA
- American Association of Clinical Endocrinologists
- Association of Program Directors in Endocrinology & Metabolism (APDEM)
- Endocrine Fellows Foundation
- Society for Endocrinology
- The Endocrine Society
- Union Endocrinology Associates
- American Association of Endocrine Surgeon
- American Thyroid Association
- National Institute of Diabetes and Digestive and Kidney Diseases
- Centres for Disease Control: Division of Diabetes Translation
The following are the top universities having the Endocrinology department:
- Harvard University
- University of Oxford
- University of Cambridge
- Johns Hopkins University
- Stanford University
- Yale University
- University of California, Los Angeles (UCLA)
- Imperial College London
- University of Melbourne
- Karolinska Institute
Top Endocrinology Societies
- The Endocrine Society of India
- German Endocrine society
- The European society of Endocrinology
- International society of Endocrinology
- Spanish society of Endocrinology
- The society of Endocrinology
The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Endocrinology Congress 2020 Report
Conference Series LLC successfully hosted its premier 11th World Congress on Endocrinology and Metabolic Disorders scheduled to be held during September 3-4, 2020 in Auckland, New Zealand. The conference was organized with a focus on “Exploring Novel Aspects in Endocrinology and Metabolic Disorders” and it was a great success where eminent keynote speakers from various reputed organizations made their resplendent presence and addressed the gathering.
Endocrinology Congress 2020 was marked by the attendance of Editorial Board Members of main Journals is Journal of Endocrinology & Metabolic Syndrome. Many Scientists, young and brilliant Researchers, Business Delegates and talented Student Communities representing from varies countries made this conference fruitful and productive driving the two-day event into the path of success with thought https://endocrine.endocrineconferences.com/registration.phpprovoking keynote and plenary presentations.
Endocrinology and Metabolism
Endocrinology and Diabetes
Endocrinology and Dermatology
Endocrinology and Pediatric Care
Types of Metabolic Disorders
The response to Endocrinology Congress 2020 was huge attendees from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the Keynote forum.
Joseph Fomusi Ndisang,
University of Saskatchewan College of Medicine, Canada
Christo John Frederick Muller
Biomedical Research and Innovation Platform, South Africa
NPIstanbul Brain Hospital, Turkey
All the above-mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions at Endocrinology Congress 2020.
All accepted abstracts have been indexed in OMICS Group Journal of Endocrinology & Metabolic Syndrome as a special issue.
We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Endocrinology Congress 2020, and with their unique feedback, Conference Series LLC would like to announce the "12th World Congress on Endocrinology and Metabolic Disorders " to be held in Osaka, Japan during May 13-14, 2020.
- Diabetes types
- Short-Term Diabetic Complications
- Diabetes in Oral Health
- Diabetic Nephropathy
- Nerve Complications in Diabetes
- Diabetes & Eye Complications
- Diabetes and Heart Diseases
- Diabetic Foot Complications
- Diabetes and Endocrinology
- Diabetic Complications
- Pediatric Diabetes
- Diabetes & Vascular Diseases
- Diabetes Nursing
To share your views and research, please click here to register for the Conference.
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by